ghk-cu + epithalon mix GHK/EPITHALON BLEND GHK‑Cu Copper Peptide Therapy |

Janoshik third-party COA independent purity verification UK-based dispatch no customs delays, no overseas handling Discreet packaging unmarked, professional delivery Secure checkout fully encrypted at every stage Balanced 5mg + 5mg formulation equal compound ratio Lyophilised stability long shelf life in original format UK-registered company verifiable via Companies House Research-use-only compliance no medical claims Frequently Asked Questions BPC-157 TB-500 10mg Peptide What is the BPC-157 TB-500 10mg peptide blend

Cao J, Belousoff MJ, Johnson RM, et al

The main point of strength of the use of peptides include selectivity, tolerability, predictable metabolism, ability to target PPIs and lower synthesis complexity that in turn leads to lower production costs compared to others pharmaceutical molecules (119, 121)

Patients who had significant swelling often report visible reduction

Current Pharmaceutical Design, 20(7), 1413-1419

BPC-157 lacks FDA approval for any medical condition, which means regulators have not confirmed its safety, effectiveness, dosing standards, or product quality